全文获取类型
收费全文 | 22181篇 |
免费 | 1223篇 |
国内免费 | 27篇 |
出版年
2023年 | 173篇 |
2022年 | 381篇 |
2021年 | 766篇 |
2020年 | 449篇 |
2019年 | 474篇 |
2018年 | 711篇 |
2017年 | 653篇 |
2016年 | 874篇 |
2015年 | 997篇 |
2014年 | 1304篇 |
2013年 | 1742篇 |
2012年 | 1854篇 |
2011年 | 1673篇 |
2010年 | 981篇 |
2009年 | 849篇 |
2008年 | 1036篇 |
2007年 | 983篇 |
2006年 | 869篇 |
2005年 | 776篇 |
2004年 | 647篇 |
2003年 | 545篇 |
2002年 | 475篇 |
2001年 | 423篇 |
2000年 | 359篇 |
1999年 | 331篇 |
1998年 | 137篇 |
1997年 | 107篇 |
1996年 | 113篇 |
1995年 | 108篇 |
1994年 | 92篇 |
1993年 | 89篇 |
1992年 | 216篇 |
1991年 | 198篇 |
1990年 | 173篇 |
1989年 | 131篇 |
1988年 | 165篇 |
1987年 | 147篇 |
1986年 | 119篇 |
1985年 | 127篇 |
1984年 | 125篇 |
1983年 | 78篇 |
1982年 | 74篇 |
1981年 | 70篇 |
1980年 | 54篇 |
1979年 | 87篇 |
1978年 | 57篇 |
1977年 | 74篇 |
1975年 | 53篇 |
1973年 | 51篇 |
1969年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 120 毫秒
991.
Noor Ahmad Shaik Huda M. Al-Kreathy Ghada M. Ajabnoor Prashant Kumar Verma Babajan Banaganapalli 《Saudi Journal of Biological Sciences》2019,26(3):439-448
The somatic mutations in ATP binding cleft of the tyrosine kinase binding domain of EGFR are known to occur in 15–40% of non-small cell lung cancer (NSCLC) patients. Although first and second generation anti-EGFR inhibitors are widely used to treat these patients, their therapeutic efficacy is modest and often results in adverse effects or drug resistance. Therefore, there is a need to develop novel as well as safe anti-EGFR drugs. The rapid emergence of computational drug designing provided a great opportunity to both discover and predict the efficacy of novel EGFR inhibitors from plant sources. In the present study, we designed several chemical analogues of edible curcumin (CUCM) compound and assessed their drug likeliness, ADME and toxicity properties using a diverse range of advanced computational methods. We also have examined the structural plasticity and binding characteristics of EGFR wild-type and mutant forms (S769L and K846R) against ligand molecules like Gefitinib, native CUCM, and different CUCM analogues. Through multidimensional experimental approaches, we conclude that CUCM-36 ((1E,4Z,6E)-1-(3,4-Diphenoxyphenyl)-5-hydroxy-7-(4-hydroxy-3-phenoxyphenyl)-1,4,6-heptatrien-3-one) is the best anti-EGFR compound with high drug-likeness, ADME properties, and low toxicity properties. CUCM-36 compound has demonstrated better affinity towards both wild-type (ΔG is ?8.5?kcal/Mol) and mutant forms (V769L & K846R; ΔG for both is >?9.20?kcal/Mol) compared to natural CUCM and Gefitinib inhibitor. This study advises the future laboratory assays to develop CUCM-36 as a novel drug compound for treating EGFR positive non-small cell lung cancer patients. 相似文献
992.
993.
994.
995.
996.
997.
998.
Reddymasu Sreenivasulu Kotthireddy Thirumal Reddy Pombala Sujitha C. Ganesh Kumar Rudraraju Ramesh Raju 《Bioorganic & medicinal chemistry》2019,27(6):1043-1055
In recent years, indole-indazolyl hydrazide-hydrazone derivatives with strong cell growth inhibition and apoptosis induction characteristics are being strongly screened for their cancer chemo-preventive potential. In the present study, N-methyl and N,N-dimethyl bis(indolyl)hydrazide-hydrazone analog derivatives were designed, synthesized and allowed to evaluate for their anti-proliferative and apoptosis induction potential against cervical (HeLa), breast (MCF-7 and MDA-MB-231) and lung (A549) cancer cell lines relative to normal HEK293 cells. The MTT assay in conjunction with mitochondrial potential assays and the trypan blue dye exclusion were employed to ascertain the effects of the derivatives on the cancer cells. Further, mechanistic studies were conducted on compound 14a to understand the biochemical mechanisms and functional interactions with various signaling pathways triggered in HeLa and MCF-7 cells. Compound 14a induced apoptosis via caspase independent pathway through the participation of mitogen-activated protein kinases (MAPK) such as extracellular signal related kinase (ERK) and p38 as well as p53 pathways. It originates the activation of pro-apoptotic proteins such as Bak and Mcl-1s and also strongly induced the generation of reactive oxygen species. In downstream signaling pathway, activated p53 protein interacted with MAPK pathways, including SAPK/c-Jun N-terminal protein kinase (JNK), p38 and ERK kinases resulting in apoptotic cell death. The involvement of MAPK cascades such as p38, ERK and p38 on compound 14a induced apoptotic cell death was evidenced by the fact that the inclusion of specific inhibitors of p38, ERK1/2 and JNK MAPK (SB2035809, PD98059 and SP600125) prevented the compound 14a towards induced apoptosis. The results clearly showed that MAP kinase cascades were crucial for apoptotic response in compound 14a induced cellular killing and were dependent on p53 activity. Based on the results, compound 14a was identified as a promising candidate for cancer therapeutics and these findings furnish a basis for further in vivo experiments on anti-proliferative activity. 相似文献
999.
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)
Alzheimer’s disease (AD) is a genetically complex, progressive and irreversible neurodegenerative disorder of the brain which involves multiple associated etiological targets. The complex pathogenesis of AD gave rise to multi-target-directed ligands (MTDLs) principle to combat this dreaded disease. Within this approach, the design and synthesis of hybrids prevailed greatly because of their capability to simultaneously target the intertwined pathogenesis components of the disease. The hybrids include pharmacophoric hybridization of two or more established chemical scaffolds endowed with the desired pharmacological properties into a single moiety. In AD, the primary foundation of medication therapy and drug design strategies includes the inhibition of cholinesterase (ChE) enzymes. Hence the development of ChE inhibition based hybrids is the central choice of AD medicinal chemistry research. To illustrate the progress of ChE inhibition based hybrids and novel targets, we reviewed the medicinal chemistry and pharmacological properties of the multi-target molecules published since 1998-December 2018. We hope that this article will allow the readers to easily follow the evolution of this prominent medicinal chemistry approach to develop a more efficient inhibitor. 相似文献
1000.
Mahbub Nafisa Oyedun Adetoyese Olajire Zhang Hao Kumar Amit Poganietz Witold-Roger 《The International Journal of Life Cycle Assessment》2019,24(5):881-899
The International Journal of Life Cycle Assessment - Due to efforts to reduce dependence on limited fossil energy reserves and increasing GHG emissions related to fossil fuel extraction and use in... 相似文献